The Motley Fool Discussion Boards

Previous Page

Stocks H / Halozyme Therapeutics


Subject:  Next Deal far away Date:  4/2/2007  10:57 AM
Author:  pokerden Number:  18 of 31

Wouldn't another deal with hti be fairly far off? Why would companies not wait to see if the Roche deal pans out?

Also, why wouldn't companies use the bovine version of the enzyme its cheaper...and would patients really care?

Copyright 1996-2018 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us